Skip to content

GRAIL, Inc. GRAL Common Stock

Common Stock at other companies

Guardant Health logo
Guardant HealthGH
$1K0.0%
Natera, Inc. logo
Natera, Inc.NTRA
750M+5,357,043%
Immunome logo
ImmunomeIMNM
$11K+22.2%
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
$16K+6.7%
Erasca, Inc. logo
Erasca, Inc.ERAS
$31K+10.7%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$5K+25.0%

Other financials

Income statement

See full
Revenue$40.8M+28.1%
Operating income-$135.8M+11.6%
Net income-$93.2M+12.3%
EPS (diluted)-$2.29+26.1%

Balance sheet

See full
Cash & equivalents$76.3M-44.4%
Total debt$51.0M-20.7%
Total equity$2.5B+3.6%
Total assets$2.8B-1.5%

Cash flow

See full
Operating cash flow-$87.0M+8.4%
CapEx$503.0K+711%
Free cash flow-$87.5M+8.0%

Valuation

See full
Market cap$2.62B+145%
Enterprise value$2.6B+164%
P/S16.8×+8.6×

Profitability

See full
Operating margin-348.7%-153pp
Net margin-253.2%-115pp
FCF margin-187.2%-60.4pp

Returns & leverage

See full
Return on equity-16.1%
Debt / equity0.0×
Current ratio11.7×+2.0×

Where this comes from

Reported directly by GRAIL, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: GRAIL, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about GRAIL, Inc.'s common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GRAIL, Inc.'s common stock?
GRAIL, Inc. (GRAL) reported common stock of 1.5B in Q1 2026.
How has GRAIL, Inc.'s common stock changed year-over-year?
GRAIL, Inc.'s common stock decreased by 0.0% year-over-year, from 1.5B to 1.5B.
What is the long-term trend for GRAIL, Inc.'s common stock?
Over 2 years (2023 to 2025), GRAIL, Inc.'s common stock has grown at a 0.0% compound annual growth rate (CAGR), from 1.5B to 1.5B.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).